Adam Stern
Net worth: 463 400 $ as of 2026-06-29
Net worth: 463 400 $ as of 2026-06-29
Mr. Adam K.
Stern is an Independent Director at VivoSim Labs, Inc. and a Chief Executive Officer & Partner at SternAegis Ventures LLC.
He is on the Board of Directors at VivoSim Labs, Inc., DarioHealth Corp., Aerami Therapeutics Holdings, Inc. and Amplifica Holdings Group, Inc. (California).
Mr. Stern was previously employed as an Independent Director by Western Acquisition Ventures Corp., an Independent Director by OPKO Biologics Ltd., a Senior Managing Director by Spencer Trask Ventures, Inc., and a SVP & Managing Director-Private Equity Marketing by Josephthal, Lyon & Ross, Inc. He also served on the board at Applied Hydroponics, Inc, Aerami Therapeutics, Inc., Matinas BioPharma Holdings, Inc., LabStyle Innovations Corp., Design Source, Inc., Adgero Biopharmaceuticals Holdings, Inc., InVivo Therapeutics Corp.
and Prolor Biotech Ltd. He received his undergraduate degree from the University of South Florida.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DARIOHEALTH CORP. 0.48% | 2025-12-21 | 35,180 ( 0.48% ) | 232 188 $ | 2026-06-29 |
| 2025-05-08 | 210,687 ( 1.54% ) | 128 940 $ | 2026-06-29 | |
Zoomcar Holdings, Inc.
Zoomcar Holdings, Inc. Finance/Rental/LeasingFinance Operates carsharing platform 7.25% | 2025-05-19 | 615,354 ( 7.25% ) | 95 380 $ | 2026-06-29 |
VIVOSIM LABS INC 0.19% | 2026-06-14 | 4,899 ( 0.19% ) | 5 242 $ | 2026-06-29 |
| 2025-09-10 | 250 ( 1.44% ) | 1 650 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| DARIOHEALTH CORP. | Director/Board Member | 2020-02-29 |
| VIVOSIM LABS, INC. | Director/Board Member | 2020-07-13 |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Develops inhaled insulin devices | Director/Board Member | - |
SternAegis Ventures LLC
SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures invests in companies located in the United States. The firm focuses on broad range of sectors. It participates in early stage capital requirements. | Chief Executive Officer | 2012-10-31 |
Amplifica Holdings Group, Inc. (California)
Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged is developing androgenic alopecia treatments | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| CYCURION, INC. | Director/Board Member | 2023-12-27 |
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 2020-11-01 |
| HYDROFARM HOLDINGS GROUP, INC. | Director/Board Member | 2019-12-31 |
| DARIOHEALTH CORP. | Director/Board Member | 2014-05-02 |
| ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 17 |
|---|---|
Augment Securities, Inc.
Augment Securities, Inc. Investment ManagersFinance Augment Securities invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in early stage capital requirements. | Finance |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
DarioHealth Corp.
DarioHealth Corp. Medical SpecialtiesHealth Technology Develops medical devices and mobile applications for self-monitoring of blood glucose | Health Technology |
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aerami Therapeutics Holdings, Inc.
Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Develops inhaled insulin devices | Health Technology |
Josephthal & Co (Broker)
Josephthal & Co (Broker) Investment Banks/BrokersFinance Brokerage firm | Finance |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivo Therapeutics Holdings Corp.
Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
SternAegis Ventures LLC
SternAegis Ventures LLC Investment ManagersFinance SternAegis Ventures invests in companies located in the United States. The firm focuses on broad range of sectors. It participates in early stage capital requirements. | Finance |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on building a robust pipeline for oncology indications | Health Technology |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Develops proprietary versions of already-approved therapeutic proteins | Health Technology |
Hydrofarm Holdings Group, Inc.
Hydrofarm Holdings Group, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and wholesales gardening equipment | Producer Manufacturing |
Western Acquisition Ventures Corp.
Western Acquisition Ventures Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Amplifica Holdings Group, Inc. (California)
Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged is developing androgenic alopecia treatments | Health Technology |
Select your edition
All financial news and data tailored to specific country editions